Astra Fuels Biotech M&A with $1.3 bln Ardea Buy

23.04.2012 - AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...